Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.

This is the first report of photodynamic therapy (PDT) in an orthotopic prostate tumor model and shows that PDT combined with surgery (tumor bed sterilization) gave significant local control of the primary tumor and significant reduction in distant metastases. By contrast, either treatment alone (surgery or PDT) gave relatively poorer local control, and PDT gave a significant increase in the mean number of lung metastases. The MatLyLu variant of the Dunning 3327 rat prostate cancer cell line, which has been selected to be metastatic to lymph nodes and lungs, was injected into the ventral lobe of the rat prostate. After 7 days, tumors were either treated by surgical removal of the ventral lobe, PDT with liposomal benzoporphyrin derivative monoacid ring A, or a combination of surgery, followed by PDT of the tumor bed. Results after 21 days showed a reduction in prostate tumor weight in all groups compared with controls, which became highly significant only for the combination group (17% of control mean tumor weight; P < 0.001; 7 of 13 clinical complete responses). The combination treatment also led to a reduction in lymph node metastasis and reductions in both the frequency and mean number of lung metastases compared with other treatment groups. The PDT-alone group, however, had a mean number of lung metastases per animal, which was nine times the control group and 34 times the combination group. These findings suggest that a tumor bed sterilization approach may be promising for locally advanced prostate cancer and suggest that factors other than local control may need to be evaluated when considering PDT for primary prostate cancer.

[1]  A. Deblasio,et al.  Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. , 1994, Cancer research.

[2]  F. Hetzel,et al.  Interstitial photodynamic therapy in the canine prostate. , 1997, British journal of urology.

[3]  R. Veenhuizen,et al.  Intraperitoneal photodynamic therapy in the rat: Comparison of toxicity profiles for photofrin and mTHPC , 1994, International journal of cancer.

[4]  B. Wilson,et al.  Photodynamic therapy for recurrent supratentorial gliomas. , 1995, Seminars in surgical oncology.

[5]  T. Hasan,et al.  PHOTOPHYSICAL AND PHOTOSENSITIZING PROPERTIES OF BENZOPORPHYRIN DERIVATIVE MONOACID RING A (BPD‐MA) * , 1994, Photochemistry and photobiology.

[6]  C. Whitehurst,et al.  Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland. , 1990, The Journal of urology.

[7]  Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas. , 1996, Archives of otolaryngology--head & neck surgery.

[8]  P. Wright,et al.  Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium. , 1998, Experimental and molecular pathology.

[9]  F. Stewart,et al.  Effect of N‐acetylcysteïne on photofrin‐induced skin photosensitivity in patients , 1995, Lasers in surgery and medicine.

[10]  R. van Hillegersberg,et al.  Adjuvant intraoperative photodynamic therapy diminishes the rate of local recurrence in a rat mammary tumour model. , 1995, British Journal of Cancer.

[11]  A H Kaye,et al.  Photodynamic therapy of brain tumors. , 1995, Journal of clinical laser medicine & surgery.

[12]  A. Partin,et al.  Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. , 1994, The Journal of urology.

[13]  L. K. Lee,et al.  In situ COMPARISON OF 665 nm and 633 nm WAVELENGTH LIGHT PENETRATION IN THE HUMAN PROSTATE GLAND , 1995, Photochemistry and photobiology.

[14]  H. Lui Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update. , 1994, Seminars in oncology.

[15]  A. Alexander,et al.  Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR. , 1997, Urology.

[16]  S. Loening,et al.  Thermal ablation of canine prostate using interstitial temperature self-regulating seeds: new treatment for prostate cancer. , 1997, Journal of endourology.

[17]  H. Oppelaar,et al.  Intraperitoneal Photodynamic Therapy: Comparison of Red and Green Light Distribution and Toxicity , 1997, Photochemistry and photobiology.

[18]  R W Keck,et al.  The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: a pilot study. , 1994, The Journal of urology.

[19]  C. Gomer,et al.  Clinical and preclinical photodynamic therapy , 1995, Lasers in surgery and medicine.

[20]  D. Dolphin,et al.  Preliminary studies on a more effective phototoxic agent than hematoporphyrin. , 1987, Journal of the National Cancer Institute.

[21]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[22]  C. Whitehurst,et al.  OPTIMIZATION OF MULTIFIBER LIGHT DELIVERY FOR THE PHOTODYNAMIC THERAPY OF LOCALIZED PROSTATE CANCER , 1993, Photochemistry and photobiology.

[23]  Michael R Hamblin,et al.  Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. , 1996, Cancer research.

[24]  T. Wieman,et al.  CHANGES IN TUMOR INTERSTITIAL PRESSURE INDUCED BY PHOTODYNAMIC THERAPY , 1991, Photochemistry and photobiology.

[25]  A. Bogdén,et al.  Proliferative response of human prostate tumour xenografts to surgical trauma and the transurethral resection of the prostate controversy. , 1996, British Journal of Cancer.

[26]  T J Dougherty,et al.  Intraoperative photodynamic therapy for retroperitoneal sarcomas , 1988, Cancer.

[27]  N S Williams,et al.  Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer , 1997, The British journal of surgery.

[28]  M R Arnfield,et al.  OPTICAL PROPERTIES OF EXPERIMENTAL PROSTATE TUMORS in vivo , 1993, Photochemistry and photobiology.

[29]  P B Cerrito,et al.  The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer Research.

[30]  D. S. Coffey,et al.  The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor. , 1981, Investigative urology.

[31]  O. Jonasson,et al.  Cancer cells in the circulating blood during operative management of genitourinary tumors. , 1961, The Journal of urology.

[32]  John A. Parrish,et al.  The Science of Photomedicine , 1982, Photobiology.

[33]  A. Bergh,et al.  Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration , 1998, The Prostate.

[34]  W Cavanagh,et al.  Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up. , 1997, Seminars in surgical oncology.

[35]  T. Patrice,et al.  Modulation of colonic cancer cell adhesiveness by haematoporphyrin derivative photodynamic therapy. , 1994, Journal of photochemistry and photobiology. B, Biology.

[36]  C. Gomer,et al.  The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. , 1987, British Journal of Cancer.

[37]  S. Loric,et al.  Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy , 1995, The Lancet.

[38]  M. Obochi,et al.  ACTIVATION OF BENZOPORPHYRIN DERIVATIVE IN THE CIRCULATION OF MICE WITHOUT SKIN PHOTOSENSITIVITY , 1994, Photochemistry and photobiology.

[39]  A. Geldof Models for cancer skeletal metastasis: a reappraisal of Batson's plexus. , 1997, Anticancer research.

[40]  P. Carroll,et al.  Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. , 1997, The Journal of urology.

[41]  R. Moore,et al.  Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  J. Oesterling,et al.  Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. , 1994, The Journal of urology.

[43]  S. Leibel,et al.  The dissemination of cancer by transurethral resection of locally advanced prostate cancer. , 1983, The Journal of urology.

[44]  A. Fortin,et al.  Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[45]  R. Auerbach Patterns of tumor metastasis: organ selectivity in the spread of cancer cells. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[46]  S. Andersson,et al.  Photodynamic therapy of localised prostatic cancer , 1990, The Lancet.

[47]  L. Gomella,et al.  Analysis of tumor spillage during radical prostatectomy using RT-PCR of prostate specific antigen. , 1996, Techniques in urology.

[48]  N S Williams,et al.  Adjuvant intraoperative photodynamic therapy for colorectal carcinoma: a clinical study. , 1994, Surgical oncology.

[49]  H. Barr,et al.  The significance of the nature of the photosensitizer for photodynamic therapy: quantitative and biological studies in the colon. , 1990, British Journal of Cancer.

[50]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[51]  E. Gilboa,et al.  An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer , 1994, The Prostate.

[52]  J. Levy,et al.  Photodynamic therapy inhibits cell adhesion without altering integrin expression. , 1997, Biochimica et biophysica acta.